Literature DB >> 22126194

Renoprotective effect of erythropoietin in ischemia/reperfusion injury: possible roles of the Akt/endothelial nitric oxide synthase-dependent pathway.

Shigeyoshi Oba1, Etsu Suzuki, Hiroaki Nishimatsu, Shintaro Kumano, Chihiro Hosoda, Yukio Homma, Yasunobu Hirata.   

Abstract

OBJECTIVES: It has been reported that erythropoietin protects the kidneys from ischemia/reperfusion injury. In the present study, we examined the role of Akt and endothelial nitric oxide synthase in the protective effect of erythropoietin on ischemia/reperfusion injury of the kidney.
METHODS: Erythropoietin was injected in the peritoneal space of ICR mice after ischemia/reperfusion injury and its effect was assessed by measuring blood urea nitrogen and creatinine, and by histological analysis. Phosphorylation of Akt and endothelial nitric oxide synthase was examined by western blot analysis. Endothelial nitric oxide synthase gene null mice were also used to examine the role of endothelial nitric oxide synthase in the renoprotective effect of erythropoietin.
RESULTS: Erythropoietin administration significantly inhibited the increase in blood urea nitrogen and creatinine after ischemia/reperfusion injury compared with control mice. Accordingly, erythropoietin administration significantly ameliorated the histological damages, including apoptotic cell death. Erythropoietin significantly stimulated phosphorylation of Akt and endothelial nitric oxide synthase in the kidneys. When endothelial nitric oxide synthase gene null mice were subjected to ischemia/reperfusion injury, erythropoietin did not significantly suppress the increase in blood urea nitrogen or creatinine.
CONCLUSIONS: Erythropoietin seems to activate the Akt/endothelial nitric oxide synthase-dependent pathway in the kidneys. This pathway might be implicated in the renoprotective effect of erythropoietin in the ischemia/reperfusion injury model.
© 2011 The Japanese Urological Association.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22126194     DOI: 10.1111/j.1442-2042.2011.02920.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  5 in total

1.  Sphk1 and Sphk2 Differentially Regulate Erythropoietin Synthesis in Mouse Renal Interstitial Fibroblast-like Cells.

Authors:  Redona Hafizi; Faik Imeri; Bisera Stepanovska Tanturovska; Roxana Manaila; Stephanie Schwalm; Sandra Trautmann; Roland H Wenger; Josef Pfeilschifter; Andrea Huwiler
Journal:  Int J Mol Sci       Date:  2022-05-24       Impact factor: 6.208

2.  ARA290, a non-erythropoietic EPO derivative, attenuates renal ischemia/reperfusion injury.

Authors:  Willem G van Rijt; Gertrude J Nieuwenhuijs-Moeke; Harry van Goor; Bente Jespersen; Petra J Ottens; Rutger J Ploeg; Henri G D Leuvenink
Journal:  J Transl Med       Date:  2013-01-09       Impact factor: 5.531

3.  Protective role of recombinant human erythropoietin in kidney and lung injury following renal bilateral ischemia-reperfusion in rat model.

Authors:  Maryam Moeini; Mehdi Nematbakhsh; Mohammad Fazilati; Ardeshir Talebi; Ali Asghar Pilehvarian; Fariba Azarkish; Fatemeh Eshraghi-Jazi; Zahra Pezeshki
Journal:  Int J Prev Med       Date:  2013-06

4.  Renoprotective capacities of non-erythropoietic EPO derivative, ARA290, following renal ischemia/reperfusion injury.

Authors:  Willem G van Rijt; Gertrude J Nieuwenhuijs-Moeke; Harry van Goor; Petra J Ottens; Rutger J Ploeg; Henri G D Leuvenink
Journal:  J Transl Med       Date:  2013-11-13       Impact factor: 5.531

5.  Attenuation of renal ischemic reperfusion injury by salvianolic acid B via suppressing oxidative stress and inflammation through PI3K/Akt signaling pathway.

Authors:  Z G Ma; H Q Xia; S L Cui; J Yu
Journal:  Braz J Med Biol Res       Date:  2017-05-15       Impact factor: 2.590

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.